(Q30322084)

17 June 2017

1 reference

title

A comprehensive review of prostate cancer brachytherapy: defining an optimal technique. (English)

1 reference

17 June 2017

1 reference

1 reference

Vicini FA

1

1 reference

17 June 2017

Kini VR

2

1 reference

17 June 2017

Edmundson G

3

1 reference

17 June 2017

Gustafson GS

4

1 reference

17 June 2017

Stromberg J

5

1 reference

17 June 2017

Martinez A

6

1 reference

17 June 2017

language of work or name

English

0 references

publication date

1 June 1999

1 reference

International Journal of Radiation Oncology Biology Physics

17 June 2017

published in

1 reference

17 June 2017

volume

44

1 reference

17 June 2017

issue

3

1 reference

17 June 2017

page(s)

483-491

1 reference

The management of clinically localized prostate cancer: guidelines from the American Urological Association

17 June 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2899%2900047-4

7 January 2021

Treatment options for localized prostate cancer based on pretreatment serum prostate specific antigen levels

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2899%2900047-4

7 January 2021

Radiotherapy options for localized prostate cancer based upon pretreatment serum prostate-specific antigen levels and biochemical control: a comprehensive review of the literature

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2899%2900047-4

7 January 2021

Assessing the variability of outcome for patients treated with localized prostate irradiation using different definitions of biochemical control

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2899%2900047-4

7 January 2021

A new device to stabilize templates for transperineal I-125 implants

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2899%2900047-4

7 January 2021

Fluoroscopic visualization of the prostatic urethra to guide transperineal prostate implantation

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2899%2900047-4

7 January 2021

Transperineal 125iodine seed implantation in prostatic cancer guided by transrectal ultrasonography

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2899%2900047-4

7 January 2021

Should brachytherapy be considered a therapeutic option in localized prostate cancer?

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2899%2900047-4

7 January 2021

Role of interstitial radiotherapy in the management of clinically organ-confined prostate cancer: the jury is still out.

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2899%2900047-4

7 January 2021

Does brachytherapy have a role in the treatment of prostate cancer?

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2899%2900047-4

7 January 2021

Permanent implants using Au-198, Pd-103 and I-125: radiobiological considerations based on the linear quadratic model

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2899%2900047-4

7 January 2021

Prostate brachytherapy. An overview

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2899%2900047-4

7 January 2021

Brachytherapy for prostate cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2899%2900047-4

7 January 2021

Centralized multiinstitutional postimplant analysis for interstitial prostate brachytherapy

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2899%2900047-4

7 January 2021

Biochemical disease-free survival following 125I prostate implantation

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2899%2900047-4

7 January 2021

Prostate specific antigen based disease control following ultrasound guided 125iodine implantation for stage T1/T2 prostatic carcinoma

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2899%2900047-4

7 January 2021

Transrectal ultrasound-guidedinterstitial radiation therapy for localized prostate cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2899%2900047-4

7 January 2021

Transperineal seed-implantation guided by biplanar transrectal ultrasound

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2899%2900047-4

7 January 2021

Transperineal palladium 103 prostate brachytherapy: analysis of morbidity and seed migration

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2899%2900047-4

7 January 2021

Posttreatment biopsy results following interstitial brachytherapy in early-stage prostate cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2899%2900047-4

7 January 2021

Guided brachytherapy for treatment of confined prostate cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2899%2900047-4

7 January 2021

Interstitial iodine-125 radiation without adjuvant therapy in the treatment of clinically localized prostate carcinoma

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2899%2900047-4

7 January 2021

A modified technique allowing interactive ultrasound-guided three-dimensional transperineal prostate implantation

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2899%2900047-4

7 January 2021

Prostate specific antigen findings and biopsy results following interactive ultrasound guided transperineal brachytherapy for early stage prostate carcinoma

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2899%2900047-4

7 January 2021

Transperineal ultrasound-guided radioactive seed implantation for organ-confined carcinoma of the prostate

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2899%2900047-4

7 January 2021

Laparoscopic pelvic lymph node dissection combined with real-time interactive transrectal ultrasound guided transperineal radioactive seed implantation of the prostate

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2899%2900047-4

7 January 2021

Ultrasonically guided transperineal seed implantation of the prostate: modification of the technique and qualitative assessment of implants

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2899%2900047-4

7 January 2021

An improved method for computerized tomography-planned transperineal 125iodine prostate implants

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2899%2900047-4

7 January 2021

Short-term freedom from disease progression after I-125 prostate implantation

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2899%2900047-4

7 January 2021

Tumor control and morbidity following transperineal iodine 125 implantation for stage T1/T2 prostatic carcinoma

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2899%2900047-4

7 January 2021

Low risk of urinary incontinence following prostate brachytherapy in patients with a prior transurethral prostate resection

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2899%2900047-4

7 January 2021

Long-term results of retropubic permanent 125iodine implantation of the prostate for clinically localized prostatic cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2899%2900047-4

7 January 2021

Outpatient ultrasound-guided palladium 103 brachytherapy for localized adenocarcinoma of the prostate: a preliminary report of 434 patients

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2899%2900047-4

7 January 2021

A dose-response study for I-125 prostate implants

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2899%2900047-4

7 January 2021

Biochemical outcome after radical prostatectomy, external beam radiation therapy, or interstitial radiation therapy for clinically localized prostate cancer.

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2899%2900047-4

7 January 2021

Ten-year disease free survival after transperineal sonography-guided iodine-125 brachytherapy with or without 45-gray external beam irradiation in the treatment of patients with clinically localized, low to high Gleason grade prostate carcinoma

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2899%2900047-4

7 January 2021

Irradiation of localized prostatic carcinoma with a combination of high dose rate iridium-192 brachytherapy and external beam radiotherapy with three target definitions and dose levels inside the prostate gland

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2899%2900047-4

7 January 2021

Combined treatment with temporary short-term high dose rate iridium-192 brachytherapy and external beam radiotherapy for irradiation of localized prostatic carcinoma

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2899%2900047-4

7 January 2021

Prostate specific antigen-monitored combination radiotherapy for patients with prostate cancer. I-125 implant followed by external-beam radiation

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2899%2900047-4

7 January 2021

Prostate-specific antigen nadir: the optimum level after irradiation for prostate cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2899%2900047-4

7 January 2021

Prostate-specific antigen nadir of 0.5 ng/mL or less defines disease freedom for surgically staged men irradiated for prostate cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2899%2900047-4

7 January 2021

103Pd brachytherapy and external beam irradiation for clinically localized, high-risk prostatic carcinoma

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2899%2900047-4

7 January 2021

Failure of open radioactive 125iodine implantation to control localized prostate cancer: a study of 41 patients

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2899%2900047-4

7 January 2021

Ultrasonically guided 125iodine seed implantation with external radiation in management of localized prostatic carcinoma

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2899%2900047-4

7 January 2021

Analysis of biopsy findings and implant quality following ultrasonically-guided 125I implantation for localised prostatic carcinoma

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2899%2900047-4

7 January 2021

Ultrasound-guided high dose rate conformal brachytherapy boost in prostate cancer: treatment description and preliminary results of a phase I/II clinical trial

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2899%2900047-4

7 January 2021

High dose combination radiotherapy for the treatment of localized prostate cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2899%2900047-4

7 January 2021

Iridium 192 high-dose-rate brachytherapy--a useful alternative therapy for localized prostate cancer?

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2899%2900047-4

7 January 2021

Fifteen-year survival and recurrence rates after radiotherapy for localized prostate cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2899%2900047-4

7 January 2021

High dose-rate afterloading 192Iridium prostate brachytherapy: feasibility report

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2899%2900047-4

7 January 2021

A "natural" volume-dose histogram for brachytherapy

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2899%2900047-4

7 January 2021

A nomograph for permanent implants of palladium-103 seeds.

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2899%2900047-4

7 January 2021

Iodine-125 implants versus external beam therapy for stages A2, B, and C prostate cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2899%2900047-4

7 January 2021

Dosimetry guidelines to minimize urethral and rectal morbidity following transperineal I-125 prostate brachytherapy

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2899%2900047-4

7 January 2021

A survey of current clinical practice of permanent prostate brachytherapy in the United States

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2899%2900047-4

7 January 2021

Optimization of permanent 125I prostate implants using fast simulated annealing.

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2899%2900047-4

7 January 2021

Dose effects of seeds placement deviations from pre-planned positions in ultrasound guided prostate implants

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2899%2900047-4

7 January 2021

Effect of edema on the post-implant dosimetry of an I-125 prostate implant: a case study

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2899%2900047-4

7 January 2021

Edema associated with I-125 or Pd-103 prostate brachytherapy and its impact on post-implant dosimetry: an analysis based on serial CT acquisition

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2899%2900047-4

7 January 2021

Optimal placement of radioisotopes for permanent prostate implants

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2899%2900047-4

7 January 2021

Problems with rigid seed strand lodging during prostate implantation: a proposed mechanism and solution

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2899%2900047-4

7 January 2021

Source placement error for permanent implant of the prostate

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2899%2900047-4

7 January 2021

Limitations of the minimum peripheral dose as a parameter for dose specification in permanent 125I prostate implants

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2899%2900047-4

7 January 2021

CT-based dosimetry for transperineal I-125 prostate brachytherapy

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2899%2900047-4

7 January 2021

Timing of computed tomography-based postimplant assessment following permanent transperineal prostate brachytherapy

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2899%2900047-4

7 January 2021

Source localization following permanent transperineal prostate interstitial brachytherapy using magnetic resonance imaging

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2899%2900047-4

7 January 2021

Intraobserver and interobserver variability of MR imaging- and CT-derived prostate volumes after transperineal interstitial permanent prostate brachytherapy.

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2899%2900047-4

7 January 2021

Comparison of MRI- and CT-based post-implant dosimetric analysis of transperineal interstitial permanent prostate brachytherapy

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2899%2900047-4

7 January 2021

Evaluation of permanent I-125 prostate implants using radiography and magnetic resonance imaging

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2899%2900047-4

7 January 2021

Prostate volumes defined by magnetic resonance imaging and computerized tomographic scans for three-dimensional conformal radiotherapy

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2899%2900047-4

7 January 2021

Tumor control probability for permanent implants in prostate

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2899%2900047-4

7 January 2021

A CT-based evaluation method for permanent implants: application to prostate

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2899%2900047-4

7 January 2021

Conformal prostate brachytherapy: initial experience of a phase I/II dose-escalating trial

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2899%2900047-4

7 January 2021

Clinical impact of implementing the recommendations of AAPM Task Group 43 on permanent prostate brachytherapy using 125I. American Association of Physicists in Medicine

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2899%2900047-4

7 January 2021

10.1016/S0360-3016(99)00047-4

Identifiers

DOI

1 reference

17 June 2017

1 reference